NCT00327652View on ClinicalTrials.gov

Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 29, 2008

Conditions
Neoplasm MetastasisLiver NeoplasmsCarcinoma
Interventions
DRUG

CRS-100

Live-attenuated Listeria monocytogenes

Trial Locations (2)

21231

Johns Hopkins University, Baltimore

75201

Mary Crowley Medical Research Center, Dallas

Sponsors
All Listed Sponsors
lead

Anza Therapeutics, Inc.

INDUSTRY

NCT00327652 - Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases | Biotech Hunter | Biotech Hunter